This NDC is on FDA's drug shortage list (posted Oct 31, 2017)
Product Information
HYDROMORPHONE 2 MG/ML CARPUJCT is a generic product labeled by Hospira Inc., priced at $3.2446 per ML under NDC 00409131230. Its NADAC has been published 74 times since Mar 19, 2025.
FDA first approved this application on Dec 1, 2011. Its Orange Book therapeutic-equivalence code is AP.
Strength
2 mg/mL
Manufacturer
Hospira Inc.NDC
00409131230
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS
Effective Date
8/20/2025
Active Ingredients
HYDROMORPHONE HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA200403FDA Approved
12/1/2011
TE Code
AP
On Market Since
2/1/2021
Pharmacological Classes
Price Statistics
The NADAC for HYDROMORPHONE 2 MG/ML CARPUJCT has been published 74 times since Mar 19, 2025, and over the history we have for it it has risen 11.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.2446 per ML |
|---|---|
| All-time high | $3.2446 (Aug 12, 2026) |
| All-time low | $2.9066 (Mar 19, 2025) |
| 52-week high | $3.2446 |
| 52-week low | $3.2446 |
| Median price | $3.2446 |
| Average price | $3.1837 |
| Largest weekly change | +3.9% (May 21, 2025) |
| Weeks tracked | 74 |
| Tracking since | Mar 19, 2025 |
1W
N/A
1M
N/A
3M
0.0%
6M
0.0%
1Y
0.0%
3Y
N/A
5Y
N/A
All
+11.6%
Last surveyed Aug 12, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the HYDROMORPHONE HYDROCHLORIDE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Hospira Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
HYDROMORPHONE HYDROCHLORIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Opioid Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of HYDROMORPHONE 2 MG/ML CARPUJCT?
The current National Average Drug Acquisition Cost (NADAC) for HYDROMORPHONE 2 MG/ML CARPUJCT, manufactured by Hospira Inc., is $3.2446 per ML (NDC 00409131230), effective Aug 12, 2026.
How has the price of HYDROMORPHONE 2 MG/ML CARPUJCT changed over time?
Over the history we have for it, the NADAC for HYDROMORPHONE 2 MG/ML CARPUJCT has risen 11.6%. It has been tracked across 74 weekly CMS publications since Mar 19, 2025.
What are the highest and lowest recorded NADAC prices for HYDROMORPHONE 2 MG/ML CARPUJCT?
Since Mar 19, 2025, the NADAC for HYDROMORPHONE 2 MG/ML CARPUJCT has ranged from a low of $2.9066 (Mar 19, 2025) to a high of $3.2446 (Aug 12, 2026), with a median of $3.2446 per ML.
Are there cheaper alternatives to HYDROMORPHONE 2 MG/ML CARPUJCT?
No other NADAC-published product currently shares the active ingredient and strength of HYDROMORPHONE 2 MG/ML CARPUJCT in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures HYDROMORPHONE 2 MG/ML CARPUJCT?
HYDROMORPHONE 2 MG/ML CARPUJCT (NDC 00409131230) is labeled by Hospira Inc., and CMS classifies it as a generic product.
Is HYDROMORPHONE 2 MG/ML CARPUJCT in shortage?
Yes — NDC 00409131230 is currently listed in FDA's drug shortage database (posted Oct 31, 2017).